Researchers are exploring strategies to alter the gut microbiome to improve patients’ responses to immunotherapy. New ...

As influencers tout methylene blue as a cognitive enhancer and anti-aging solution, experts caution about its serious risks ...

The Felix NeuroAI wristband delivers tailored and dynamic electrical stimulation to the ulnar, median, and radial nerves ...

Physicians are turning to other options, including older, cheaper medications, as compounding GLP-1s comes to an end.

A new study has revealed significant reductions in cancer deaths across Europe, yet critical challenges persist for specific ...

Over a 12-week period, yoga proves noninferior to strengthening exercises in significantly reducing knee pain.

Medical groups are pressing their members to keep healthcare a priority for federal officials in an election campaign ...

A study aims to explore whether individuals eligible for lung cancer screening also access other preventive services.

Inebilizumab, a first-in-class CD19+ B-cell–targeting agent, is safe and effective for up to 1 year in patients with generalized myasthenia gravis, a phase 3 trial suggests.

A device in clinical development appears to be far safer and more effective than the TAVI devices currently being used ...

Decreased levels of resolvin D1 are linked to prolonged respiratory symptoms and slower clinical recovery in patients with ...

Two endocrinologists who live with type 1 diabetes debate this issue at the Advanced Technologies & Treatments for Diabetes ...